Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-071788

Alaunos Therapeutics, Inc. · TCRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Randal J Kirk
Director · 10% Owner
INTREXON CORP
10% Owner
Period of report
Jul 1, 2016
Accepted (ET)
Jul 6, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———122,309D
Common StockF1holding———3,479,685Iby R.J. Kirk DOT
Common StockF1holding———23,349Iby JPK 2008
Common StockF1holding———23,504Iby MGK 2008
Common StockF1holding———40,954Iby ZSK 2008
Common StockF1holding———240Iby Lotus
Common StockF1holding———53,245Iby Staff 2001
Common StockF1holding———9,537Iby Sr. Staff
Common StockF1holding———337,333Iby JPK 2009
Common StockF1holding———358,386Iby MGK 2009
Common StockF1holding———34,318Iby ZSK 2009
Common StockF1holding———29,066Iby ADC 2010
Common StockF1holding———154,181Iby MGK 2011
Common StockF1holding———138,975Iby JPK 2012
Common StockF1holding———61,262Iby Kellie L. Banks LTT
Common StockF2holding———2,359,608Iby Kapital Joe
Common StockF2holding———889,513Iby Mascara Kaboom
Common StockF2holding———395,791Iby Senior Staff 2008
Common StockF2holding———222,680Iby Staff 2010
Common StockF2holding———111,339Iby Incentive 2010
Common StockF2holding———352,477Iby Senior Staff 2007
Common StockF2holding———176,238Iby Staff 2007
Common StockF2holding———58,746Iby Incentive 2007
Common StockF2holding———173,111Iby Staff 2009
Common StockF2holding———86,556Iby Incentive 2009

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series 1 Preferred StockF4,F5,F3—Jun 30, 2016P100,000A——Common Stock—100,000I

Explanation of responses